Abbott Laboratories
NYSE:ABT
Relative Value
The Relative Value of one ABT stock under the Base Case scenario is 124.7 USD. Compared to the current market price of 105.27 USD, Abbott Laboratories is Undervalued by 16%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
ABT Competitors Multiples
Abbott Laboratories Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Abbott Laboratories
NYSE:ABT
|
182.1B USD | 4.6 | 31.8 | 18.9 | 28 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
131B USD | 18.4 | 72.9 | 56.2 | 70.6 | ||
US |
Stryker Corp
NYSE:SYK
|
125.8B USD | 6.1 | 39.7 | 24.8 | 30.6 | ||
IE |
Medtronic PLC
NYSE:MDT
|
104.4B USD | 3.3 | 24.9 | 13.3 | 18.8 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
99.3B USD | 6.9 | 63.3 | 29.5 | 44.1 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
66.7B USD | 3.5 | 54.8 | 18.4 | 38.8 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
57.3B EUR | 2.6 | 37.7 | 18.2 | 30.6 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
52.1B USD | 8.7 | 37.1 | 26.9 | 29.1 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
51.9B USD | 14.3 | 95.6 | 64.5 | 84 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
329.2B CNY | 9.6 | 29 | 25.1 | 25.1 | ||
US |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
39.9B USD | 10.8 | 46.9 | 33.2 | 36.7 |